Yong‐Jin Wu

1.7k citations

57 papers · 960 indexed · h-index 19

Organic Chemistry top 5%
Molecular Biology
Pharmacology top 10%
Cellular and Molecular Neuroscience
Computational Theory and Mathematics top 10%

Co-authors: Huan He D. Jean Burnell Nicholas A. Meanwell Alexandre L’Heureux Yong Tao Derrick L. J. Clive Yunhui Zhang John E. Macor
Topics: Chemical Synthesis and Analysis (10 papers)Asymmetric Synthesis and Catalysis (9 papers)Catalytic Cross-Coupling Reactions (8 papers)
Cited by: Organic Chemistry Toxicology Pharmaceutical Science
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry The Journal of Organic Chemistry
Partner nations: United States Canada Germany

In The Last Decade

Yong‐Jin Wu

57 papers receiving 915 citations

Peers

Countries citing papers authored by Yong‐Jin Wu

Since Specialization

Citations

This map shows the geographic impact of Yong‐Jin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Jin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Jin Wu more than expected).

Fields of papers citing papers by Yong‐Jin Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Jin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Jin Wu. The network helps show where Yong‐Jin Wu may publish in the future.

Co-authorship network of co-authors of Yong‐Jin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Jin Wu. A scholar is included among the top collaborators of Yong‐Jin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Jin Wu. Yong‐Jin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficient and provably secured puncturable attribute-based signature for Web 3.0 2024 ·Future Generation Computer Systems ·Yong‐Jin Wu,Hu Xiong,Fazlullah Khan,Samreen Ijaz,Ryan Alturki,Abeer Aljohani	3
2	5-Bromo-2-chloro-4-fluoro-3-iodopyridine as a Halogen-rich Intermediate for the Synthesis of Pentasubstituted Pyridines 2022 ·The Journal of Organic Chemistry ·Yong‐Jin Wu,(unknown),David B. Frennesson,Mark G. Saulnier	4
3	Synthesis of functionalized derivatives of the gamma-secretase modulator BMS-932481 and identification of its major metabolite 2020 ·Bioorganic & Medicinal Chemistry Letters ·Yunhui Zhang,(unknown),Yong‐Jin Wu,Antonio Ramı́rez,Jeremy H. Toyn,Michael K. Ahlijanian,Charles F. Albright,Xiaoliang Zhuo,Benjamin M. Johnson,Rex Denton,Richard E. Olson,Lorin A. Thompson,John E. Macor	3
4	Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,(unknown),(unknown),Brian L. Venables,Ramkumar Rajamani,Kevin J. Robbins,Ronald J. Knox,(unknown),Rick L. Pieschl,James Herrington,Linda J. Bristow,Nicholas A. Meanwell,Richard E. Olson,Lorin A. Thompson,Carolyn D. Dzierba	6
5	Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,Brian L. Venables,(unknown),Jie Chen,Sing‐Yuen Sit,Ramkumar Rajamani,Ronald J. Knox,(unknown),Rick L. Pieschl,James Herrington,Linda J. Bristow,Nicholas A. Meanwell,Lorin A. Thompson,Carolyn D. Dzierba	5
6	Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liability 2018 ·Bioorganic & Medicinal Chemistry Letters ·Darren W. Engers,(unknown),Julie L. Engers,Joseph D. Panarese,(unknown),Alison R. Gregro,Anna L. Blobaum,Joanne J. Bronson,Yong‐Jin Wu,John E. Macor,Alice L. Rodriguez,Rocio Zamorano,P. Jeffrey Conn,Craig W. Lindsley,Colleen M. Niswender,Corey R. Hopkins	8
7	Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,(unknown),Ramkumar Rajamani,Jeremy H. Toyn,Michael K. Ahlijanian,Charles F. Albright,J.K. Muckelbauer,ChiehYing Y. Chang,(unknown),John E. Macor,Lorin A. Thompson	14
8	Synthesis of pyrimido[4,5-c]azepine- and pyrimido[4,5-c]oxepine-based γ-secretase modulators 2016 ·Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,Yunhui Zhang,Jeremy H. Toyn,John E. Macor,Lorin A. Thompson	6
9	Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE) 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Yong‐Jin Wu,Yunhui Zhang,(unknown),Weixu Zhai,Shirong Zhu,Samuel W. Gerritz,Jeremy H. Toyn,Jere E. Meredith,Donna M. Barten,Catherine R. Burton,Charles F. Albright,Andrew C. Good,James E. Grace,Kimberley A. Lentz,Richard E. Olson,John E. Macor,Lorin A. Thompson	13
10	Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist–serotonin reuptake transporter inhibitor 2014 ·Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,Huan He,Qi Gao,Dedong Wu,Robert L. Bertekap,Ryan S. Westphal,Snježana Lelas,Amy Newton,Tanya L. Wallace,Matthew T. Taber,Carl D. Davis,John E. Macor,Joanne J. Bronson	4
11	Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists–serotonin reuptake transporter inhibitors for the treatment of depression 2013 ·Bioorganic & Medicinal Chemistry ·Yong‐Jin Wu,Huan He,Robert L. Bertekap,Ryan S. Westphal,Snježana Lelas,Amy Newton,Tanya L. Wallace,Matthew T. Taber,Carl D. Davis,John E. Macor,Joanne J. Bronson	20
12	Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavir 2011 ·Journal of Antimicrobial Chemotherapy ·Jane Zhang,Li Zhu,(unknown),(unknown),Xiaohui Xu,Yong‐Jin Wu,Dilek Arikan,Achmad Farajallah,Richard Bertz	16
13	Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACE 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,Yunhui Zhang,Andrew C. Good,Catherine R. Burton,Jeremy H. Toyn,Charles F. Albright,John E. Macor,Lorin A. Thompson	11
14	(S,E)-N-[1-(3-Heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity 2004 ·Bioorganic & Medicinal Chemistry Letters ·Alexandre L’Heureux,Alain Martel,Huan He,Jie Chen,Li‐Qiang Sun,John E. Starrett,(unknown),Steven I. Dworetzky,Ronald J. Knox,David Harden,David T. Weaver,Mark Thompson,Yong‐Jin Wu	6
15	(S)-N-[1-(4-Cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neurons 2004 ·Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,Christopher G. Boissard,Jie Chen,(unknown),Qi Gao,Valentin K. Gribkoff,David Harden,Huan He,Ronald J. Knox,(unknown),Rick L. Pieschl,John E. Starrett,Li‐Qiang Sun,M. D. Thompson,David T. Weaver,Dedong Wu,Steven I. Dworetzky	23
16	(S)‐N‐[1‐(4‐Cyclopropylmethyl‐3,4‐dihydro‐2H‐benzo [1,4]oxazin‐6‐yl)‐ethyl]‐3‐(2‐fluoro‐phenyl)‐acrylamide Is a Potent and Efficacious KCNQ2 Opener which Inhibits Induced Hyperexcitability of Rat Hippocampal Neurons. 2004 ·ChemInform ·Yong‐Jin Wu,(unknown)	1
17	Synthesis and Structure−Activity Relationship of Acrylamides as KCNQ2 Potassium Channel Openers 2004 ·Journal of Medicinal Chemistry ·Yong‐Jin Wu,Huan He,Li‐Qiang Sun,Alexandre L’Heureux,Jie Chen,(unknown),John E. Starrett,Christopher G. Boissard,Valentin K. Gribkoff,(unknown),Steven I. Dworetzky	32
18	Copper-Catalyzed Cross-Coupling of Aryl Halides and Thiols Using Microwave Heating 2003 ·Synlett ·Yong‐Jin Wu,Huan He	71
19	A spiro-annulation approach to the zizaane sesquiterpenes 1990 ·Canadian Journal of Chemistry ·D. Jean Burnell,Yong‐Jin Wu	22
20	A very short synthesis of 3-methoxyestra-1,3,5,8,14-pentaen-17-one 1989 ·Canadian Journal of Chemistry ·D. Jean Burnell,Yong‐Jin Wu	9

About Yong‐Jin Wu

Yong‐Jin Wu is a scholar working on Organic Chemistry, Pharmaceutical Science and Biotechnology, having authored 57 papers that have together received 960 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (10 papers), Asymmetric Synthesis and Catalysis (9 papers) and Catalytic Cross-Coupling Reactions (8 papers). The work is most often cited by research in Organic Chemistry (714 citations), Toxicology (28 citations) and Pharmaceutical Science (36 citations). Yong‐Jin Wu has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Huan He, D. Jean Burnell, Nicholas A. Meanwell, Alexandre L’Heureux, Yong Tao, Derrick L. J. Clive, Yunhui Zhang, John E. Macor, Li‐Qiang Sun and Lorin A. Thompson. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact